awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q35788245-452B4624-E673-4016-8AE7-D126A68CA38F
Q35788245-452B4624-E673-4016-8AE7-D126A68CA38F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35788245-452B4624-E673-4016-8AE7-D126A68CA38F
The development of potential antibody-based therapies for myeloma
P2860
Q35788245-452B4624-E673-4016-8AE7-D126A68CA38F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35788245-452B4624-E673-4016-8AE7-D126A68CA38F
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
2e338db1a6e33f3c92be5d663dd771d227bc3834
P2860
Phase I trial of anti-CS1 monoclonal antibody elotuzumab in combination with bortezomib in the treatment of relapsed/refractory multiple myeloma